Search Results

You are looking at 1 - 10 of 17 items for :

  • "gastric bypass" x
Clear All
Open access

Marloes Emous, Merel van den Broek, Ragnhild B Wijma, Loek J M de Heide, Gertjan van Dijk, Anke Laskewitz, Erik Totté, Bruce H R Wolffenbuttel and André P van Beek

Introduction The laparoscopic Roux-en-Y gastric bypass (RYGB) is often used to achieve sustained weight loss, resolve comorbidity and improve survival in patients with obesity ( 1 ). It is an effective procedure, but unfortunately, it can be

Open access

Magnolia Ariza-Nieto, Joshua B Alley, Sanjay Samy, Laura Fitzgerald, Francoise Vermeylen, Michael L Shuler and José O Alemán

collaborative study also received approval from the Cornell University Office of Research Integrity and Assurance (# 1209003265). All patients scheduled to undergo Roux-en-Y Gastric Bypass (RYGB), referred herein as metabolic surgery were eligible to participate

Open access

Alexis Sudlow, Carel W le Roux and Dimitri J Pournaras

indicated that the two most commonly performed procedures were sleeve gastrectomy (45.9%) and Roux-en-Y gastric bypass (38.3%). There was a general trend indicating the increasing popularity of sleeve gastrectomy and significant decreases in the number of

Open access

Henri Honka, Jukka Koffert, Saila Kauhanen, Nobuyuki Kudomi, Saija Hurme, Andrea Mari, Andreas Lindqvist, Nils Wierup, Riitta Parkkola, Leif Groop and Pirjo Nuutila

-diabetic control. Experimental study design (B). Arrows indicate radiotracer administration and black bars abdominal PET scan, respectively. 15 O-CO, 15 O-carbon monoxide. Bariatric surgery Surgical procedures (either Roux-en-Y gastric bypass

Open access

David P Sonne, Asger Lund, Jens Faber, Jens J Holst, Tina Vilsbøll and Filip K Knop

-diabetic patients who had undergone Roux-en-Y gastric bypass surgery, and recent reports have demonstrated similar associations of bile acids with TSH in type 2 diabetes (6, 7, 8) . In contrast, Brufau et al . (9) could not demonstrate any effect of bile acids

Open access

Signe Frøssing, Malin Nylander, Caroline Kistorp, Sven O Skouby and Jens Faber

) and gastric bypass surgery ( 27 ), although changes in MR-proADM and BMI did not correlated despite excessive weight loss ( 27 ). This is in accordance with our results of a 6% borderline significant reduction in MR-proADM levels ( P  = 0.057) with no

Open access

Dorte Glintborg, Hanne Mumm, Jens Juul Holst and Marianne Andersen

development of obesity by increasing appetite-evoking hormones such as leptin ( 10 ). Increased GLP-1 activity contributed to hypoglycemia after gastric bypass ( 11 ), but possible associations between RH and GLP-1 levels in PCOS have not been investigated

Open access

Kristin Ottarsdottir, Anna G Nilsson, Margareta Hellgren, Ulf Lindblad and Bledar Daka

, suggesting that body composition but not insulin resistance is associated in a bidirectional manner with testosterone levels. The impact of body composition on testosterone is further supported by observations in individuals undergoing gastric bypass surgery

Open access

Annieke C G van Baar, Andrei Prodan, Camilla D Wahlgren, Steen S Poulsen, Filip K Knop, Albert K Groen, Jacques J Bergman, Max Nieuwdorp and Evgeni Levin

in subjects with type 2 diabetes ( 5 ). Rerouting of nutrients to L cell-rich parts of the gastrointestinal tract, as seen after gastric bypass surgery, enhances the postprandial GLP-1 responses ( 6 ), which in turn – like exogenous administration of

Open access

Frederique Van de Velde, Marlies Bekaert, Anja Geerts, Anne Hoorens, Arsène-Hélène Batens, Samyah Shadid, Margriet Ouwens, Yves Van Nieuwenhove and Bruno Lapauw

number B67020084018), 71 men with obesity who were scheduled for gastric bypass surgery (GBS) were included. These men met the national reimbursement criteria for GBS since they had either a BMI >40 kg/m 2 or a BMI >35 kg/m 2 with at least one of the